Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma

Table 1 Number of signals by percentage of analyzed nuclei

Case	Age (yr)	Origin	HT	UICC	Immunostaining	Probe	Percentage of nuclei
							Number of signals
							1	2	3	4	5	≥ 6	HA
1	77	Antrum	Intestinal	T2N1M0	Nuclear	C-MYC	0	34	23	25	14	2	2
						Chrom.8	0	58	33	9	0	0	-
2	48	Antrum	Intestinal	T4N0M0	Nuclear	C-MYC	0	35	10	20	29	2	4
						Chrom.8	0	70	21	6	3	0	-
3	74	Antrum	Diffuse	T1N0M0	Nuclear/Cytoplasmatic	C-MYC	1	38	29	30	2	0	0
						Chrom.8	2	59	19	18	2	0	-
4	74	Antrum/body	Intestinal	T4N0M0	Nuclear	C-MYC	0	40	12	28	17	2	1
						Chrom.8	0	63	25	1	1	0	-
5	41	Antrum	Intestinal	T2N0M0	Nuclear	C-MYC	0	36	18	30	13	2	1
						Chrom.8	4	61	30	4	1	0	-
6	56	Antrum/body	Diffuse	T2N1M0	Nuclear/Cytoplasmatic	C-MYC	0	31	38	17	14	0	0
						Chrom.8	3	60	32	5	1	0	-
7	55	Antrum	Intestinal	T4N2M1	Nuclear	C-MYC	2	48	27	7	7	3	6
						Chrom.8	2	54	27	5	4	8
Control	77	Stomach tissue	-	-	Without staining	C-MYC	2	98	0	0	0	0	0
						Chrom.8	1	96	3	0	0	0	-
Control	37	Lymphocytes	-	-	Without staining	C-MYC	0.5	99.5	0	0	0	0	0
						Chrom.8	1	98.5	0.5	0	0	0	-

HT: Histological type; UICC: Union Internationale Contre le Cancer; HA: High amplification.